These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Roh JL, Yeo NK, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY. Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656 [Abstract] [Full Text] [Related]
44. Limitations of FDG-PET and FDG-PET with computed tomography for detecting synchronous cancer in pharyngeal cancer. Suzuki H, Hasegawa Y, Terada A, Ogawa T, Hyodo I, Suzuki M, Nakashima T, Tamaki T, Nishio M. Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1191-5. PubMed ID: 19015450 [Abstract] [Full Text] [Related]
49. Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography. Kim K, Park SJ, Kim BT, Lee KS, Shim YM. Ann Thorac Surg; 2001 Jan; 71(1):290-4. PubMed ID: 11216764 [Abstract] [Full Text] [Related]
55. The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial. Meyers BF, Downey RJ, Decker PA, Keenan RJ, Siegel BA, Cerfolio RJ, Landreneau RJ, Reed CE, Balfe DM, Dehdashti F, Ballman KV, Rusch VW, Putnam JB, American College of Surgeons Oncology Group Z0060. J Thorac Cardiovasc Surg; 2007 Mar; 133(3):738-45. PubMed ID: 17320575 [Abstract] [Full Text] [Related]